{
    "pmcid": "8126837",
    "qa_pairs": {
        "What is the primary target for neutralizing antibodies within the SARS-CoV-2 spike protein?": [
            "The receptor-binding domain (RBD)",
            "The N-terminal domain (NTD)",
            "The S2 subunit",
            "The fusion peptide"
        ],
        "What method was used to identify high-affinity nanobodies in the study?": [
            "Phage display",
            "Yeast surface display",
            "Bacterial display",
            "Ribosome display"
        ],
        "What was the effect of prophylactic administration of nanobody cocktails in mice?": [
            "Significantly reduced viral loads",
            "Increased viral replication",
            "No effect on viral loads",
            "Caused adverse immune reactions"
        ],
        "Which mutations are specifically mentioned as affecting viral transmission and antibody neutralization in the paper?": [
            "D614G and N501Y",
            "E484K and L452R",
            "K417N and P681R",
            "T478K and A222V"
        ],
        "Which nanobodies were identified as having high neutralization potency against SARS-CoV-2 variants?": [
            "WNb 2 and WNb 36",
            "WNb 5 and WNb 12",
            "WNb 8 and WNb 15",
            "WNb 20 and WNb 25"
        ]
    }
}